Journal
JOURNAL OF CLINICAL MEDICINE
Volume 10, Issue 11, Pages -Publisher
MDPI
DOI: 10.3390/jcm10112419
Keywords
metabolic disorder; platelets; coagulation factors; hypercoagulation; hypofibrinolysis
Categories
Funding
- Chinese Scholarship Council (CSC) fellowship program
Ask authors/readers for more resources
Patients with diabetes are prone to a prothrombotic state due to metabolic disorders, which can be managed with appropriate anticoagulation therapies and metabolic optimizations. Current guidelines lack recommendations on the optimal antithrombotic treatment for these patients.
In patients with diabetes, metabolic disorders disturb the physiological balance of coagulation and fibrinolysis, leading to a prothrombotic state characterized by platelet hypersensitivity, coagulation disorders and hypofibrinolysis. Hyperglycemia and insulin resistance cause changes in platelet number and activation, as well as qualitative and/or quantitative modifications of coagulatory and fibrinolytic factors, resulting in the formation of fibrinolysis-resistant clots in patients with diabetes. Other coexisting factors like hypoglycemia, obesity and dyslipidemia also contribute to coagulation disorders in patients with diabetes. Management of the prothrombotic state includes antiplatelet and anticoagulation therapies for diabetes patients with either a history of cardiovascular disease or prone to a higher risk of thrombus generation, but current guidelines lack recommendations on the optimal antithrombotic treatment for these patients. Metabolic optimizations like glucose control, lipid-lowering, and weight loss also improve coagulation disorders of diabetes patients. Intriguing, glucose-lowering drugs, especially cardiovascular beneficial agents, such as glucagon-like peptide-1 receptor agonists and sodium glucose co-transporter inhibitors, have been shown to exert direct anticoagulation effects in patients with diabetes. This review focuses on the most recent progress in the development and management of diabetes related prothrombotic state.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available